Craig Wong-Pan
Stock Analyst at RBC Capital
(0.97)
# 3,946
Out of 4,683 analysts
325
Total ratings
46.9%
Success rate
-1.3%
Average return
Main Sectors:
Stocks Rated by Craig Wong-Pan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: NAN Nanosonics Limited | Maintained: Hold | $3.50 → $3.00 | $2.67 | +12.36% | 19 | Aug 25, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Maintained: Buy | $2.60 → $3.20 | $2.33 | +37.34% | 24 | Aug 25, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Maintained: Hold | $34.00 → $39.00 | $44.20 | -11.76% | 5 | Aug 20, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Hold | $18.00 → $19.00 | $15.58 | +21.95% | 8 | Aug 20, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Hold | $22.00 → $21.00 | $20.10 | +4.48% | 26 | Aug 20, 2026 | |
| ASX: HLS Healius Limited | Maintained: Sell | $0.35 → $0.37 | $0.44 | -14.94% | 31 | Aug 19, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Hold | $117.00 | $137.76 | -15.07% | 22 | Aug 18, 2026 | |
| ASX: CSL CSL Limited | Maintained: Hold | $108.00 → $148.00 | $173.88 | -14.88% | 34 | Aug 18, 2026 | |
| ASX: ACL Australian Clinical Labs Limited | Maintained: Hold | $2.35 → $2.40 | $2.82 | -14.89% | 21 | Aug 17, 2026 | |
| RMD ResMed | Maintained: Hold | $234 → $244 | $237.74 | +2.63% | 37 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $84 | $124.18 | -32.32% | 1 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41.00 → $36.00 | $40.29 | -10.65% | 8 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45.00 → $49.00 | $50.06 | -2.12% | 22 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.50 | $6.15 | +21.95% | 28 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.13 → $0.12 | $0.10 | +25.00% | 23 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.75 → $0.72 | $0.67 | +7.46% | 13 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $16.04 | $28.23 | n/a | 1 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31.60 | $14.65 | n/a | 1 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $6.57 | $22.39 | n/a | 1 | May 22, 2019 |
Nanosonics Limited
Aug 25, 2026
Maintained: Hold
Price Target: $3.50 → $3.00
Current: $2.67
Upside: +12.36%
Integral Diagnostics Limited
Aug 25, 2026
Maintained: Buy
Price Target: $2.60 → $3.20
Current: $2.33
Upside: +37.34%
Fisher & Paykel Healthcare Corporation Limited
Aug 20, 2026
Maintained: Hold
Price Target: $34.00 → $39.00
Current: $44.20
Upside: -11.76%
Telix Pharmaceuticals Limited
Aug 20, 2026
Maintained: Hold
Price Target: $18.00 → $19.00
Current: $15.58
Upside: +21.95%
Sonic Healthcare Limited
Aug 20, 2026
Maintained: Hold
Price Target: $22.00 → $21.00
Current: $20.10
Upside: +4.48%
Healius Limited
Aug 19, 2026
Maintained: Sell
Price Target: $0.35 → $0.37
Current: $0.44
Upside: -14.94%
Cochlear Limited
Aug 18, 2026
Maintained: Hold
Price Target: $117.00
Current: $137.76
Upside: -15.07%
CSL Limited
Aug 18, 2026
Maintained: Hold
Price Target: $108.00 → $148.00
Current: $173.88
Upside: -14.88%
Australian Clinical Labs Limited
Aug 17, 2026
Maintained: Hold
Price Target: $2.35 → $2.40
Current: $2.82
Upside: -14.89%
ResMed
Aug 7, 2026
Maintained: Hold
Price Target: $234 → $244
Current: $237.74
Upside: +2.63%
Jul 16, 2026
Downgraded: Hold
Price Target: $84
Current: $124.18
Upside: -32.32%
Jul 16, 2026
Maintained: Buy
Price Target: $41.00 → $36.00
Current: $40.29
Upside: -10.65%
Jul 16, 2026
Maintained: Hold
Price Target: $45.00 → $49.00
Current: $50.06
Upside: -2.12%
Jul 16, 2026
Maintained: Buy
Price Target: $7.50
Current: $6.15
Upside: +21.95%
Jul 16, 2026
Maintained: Hold
Price Target: $0.13 → $0.12
Current: $0.10
Upside: +25.00%
Jun 11, 2026
Maintained: Hold
Price Target: $0.75 → $0.72
Current: $0.67
Upside: +7.46%
Oct 6, 2020
Maintained: Sell
Price Target: $16.04
Current: $28.23
Upside: n/a
Oct 6, 2020
Maintained: Buy
Price Target: $31.60
Current: $14.65
Upside: n/a
May 22, 2019
Downgraded: Sell
Price Target: $6.57
Current: $22.39
Upside: n/a